Modified VAD and PSC-833 in the treatment of resistant or relapsing chronic lymphocytic leukemia (E4996): A trial of the Eastern Cooperative Oncology Group

William R. Friedenberg, Martin S. Tallman, Isadore Brodsky, Elisabeth Paietta, Jacob M. Rowe, Sandra J. Lee, Kendrith M. Rowland, George W. Schnetzer, John C. Reed

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Modified VAD and PSC-833 in the treatment of resistant or relapsing chronic lymphocytic leukemia (E4996): A trial of the Eastern Cooperative Oncology Group'. Together they form a unique fingerprint.

Medicine & Life Sciences